Loading…

Shockwave Medical has signed an agreement to form a joint venture with Genesis MedTech Group to commercialize coronary and peripheral IVL products in mainland China.
“This joint venture represents another step in the continuation of our strategy to ensure that patients around the world have access to IVL and to do so with a strong, local presence.”shockwavemedical.com
Summarized from public sources; check the original articles before acting on it.